[HTML] thieme-connect.com

[HTML][HTML] Diagnosis, staging, and patient selection for locoregional therapy to treat hepatocellular carcinoma

ZT Berman, I Newton - Seminars in Interventional Radiology, 2020 - thieme-connect.com
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
and the only cancer for which the incidence and mortality are on the rise. Sensitive and …
被引用次数：9 相关文章

Diagnosis, Staging, and Patient Selection for Locoregional Therapy to Treat Hepatocellular Carcinoma.

I Newton, Z Berman - Seminars in Interventional Radiology, 2020 - escholarship.org
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
and the only cancer for which the incidence and mortality are on the rise. Sensitive and …

Diagnosis, Staging, and Patient Selection for Locoregional Therapy to Treat Hepatocellular Carcinoma

ZT Berman, I Newton - Seminars in interventional …, 2020 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
and the only cancer for which the incidence and mortality are on the rise. Sensitive and …
[HTML] nih.gov

[HTML][HTML] Seminars in IR Liver Oncology: Diagnosis, Staging, and Patient Selection for Locoregional Therapy to Treat Hepatocellular Carcinoma

ZT Berman, I Newton - Seminars in Interventional Radiology, 2020 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
and the only cancer for which the incidence and mortality are on the rise. Sensitive and …

Diagnosis, Staging, and Patient Selection for Locoregional Therapy to Treat Hepatocellular Carcinoma.

ZT Berman, I Newton - Seminars in Interventional Radiology, 2020 - europepmc.org
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
and the only cancer for which the incidence and mortality are on the rise. Sensitive and …